In 2017, during the specialized road show, the Moscow International Medical Cluster (MIMC) was introduced to more than 500 foreign clinics from 22 countries of the world as well as private Russian and international investors. The government, on its part, committed to invest over 9 bn rubles in the cluster. In 2018, the first facility of the cluster, the Diagnostics & Outpatient Center, will open its doors to patients. Hadassah, an Israeli medical center, the first participant of the cluster, became its medical operator.
The Moscow International Medical Cluster is a platform for rapid transfer of international medical technologies and knowledge to Russia and for fostering the future Russian medical elite.
After completion of the road show of the Moscow Medical International Cluster, 25 international medical operators are now expressing interest in participation in the cluster and are ready for negotiations with investors. These are clinics and medical consortiums from Israel, Germany, Austria, France, Spain, Poland, Finland, South Korea, USA, Japan. They are leaders in such fields as oncology, cardiology, rehabilitation, orthopedics, pediatrics, urology, preventive health care and longevity, corporate health.
Foreign medical operators are ready to open their clinics in the medical cluster in order to offer superb medical care and transfer their knowledge and health care culture to Russian doctors. One of the preconditions for operators to join the cluster is provision of educational programs for Russian doctors whose share in the clinics will comprise at least 75%.
For the time being, the Israeli Rambam medical center and Schneider Children's Medical Center of Israel, the Centre Leon Berard and Сlinique Chirurgicale Saint Charles, France, Sanlas Holding GMBH, Austria, Urologische Klinik München-Planegg, Germany, the Institute for Health and Productivity Management (IHPM), USA, have publicly disclosed their interest in entering the Russian market. Other medical operators prefer to keep their plans to enter the Russian market confidential.
During the road show, the most effective formula for implementation of clinic projects in the MIMC was determined. This is a union of an international medical operator and a Russian investor. The former possess unique expertise and techniques, while the latter have a good understanding of the Russian business specifics and are interested in implementation of projects which will be not only commercially attractive but also socially significant. An excellent illustration of such a union is the intention of a Russian investor, Tashir Medica (belonging to the Tashir Group of Companies), to invest 15 bn rubles in the MIMC's Hospital of the Future project to be implemented together with Seoul National University Bundang Hospital.
Another landmark event for the Moscow International Medical Cluster was signing of the strategic cooperation agreement with Sberbank. The Bank is considering supporting MIMC in attracting investors and acting as a project investor. The agreement also envisages consideration of options for participation of the Sberbank employees and corporate clients in health care programs of the Cluster.
The Moscow International Medical Cluster is being built on 57 hectares in the Skolkovo Innovation Center. The Skolkovo Innovation Center is Russia's largest innovation complex for development and commercialization of innovative technologies. It accommodates 5 innovation clusters, the Technopark, the Skolkovo Institute of Science and Technology, R&D centers are being built for 50 industrial partners. Not only clinics but also education centers and R&D centers will operate in the Moscow International Medical Cluster. Russian innovative projects will be able to find an international partner in MIMC and to develop their products in line with international health care standards in order to access global markets.
The territory of the medical cluster is the only area in Russia where the Federal law has removed administrative barriers to allow foreign clinics to work in accordance with their standards subject to availability of all permits and registrations obtained in their home countries
- Treatment protocols and medical methods can be used without licensing mandatory for implementation of medical activities in Russia;
- Medicinal drugs and equipment may be used without registration in Russia;
- Educational degrees of foreign medical, educational and scientific staff do not need to be validated, and work permits are not limited by quotas.
"In the past year, we have done a huge work to present the Moscow International Medical Cluster abroad to potential cluster participants. Before the road show, we performed analysis and made a list of medical operators, taking into account their rating and international experience. The team of the Foundation had hundreds of meetings abroad and in Russia, presented the cluster at major conferences and during visits with Russian diplomatic missions. But the most important conclusion we drew from the road show was that global transformational projects are driven by individuals – visionaries, strategists and leaders of the new economic setting – rather than organizations," commented Mikhail Yugay, CEO of the IMC Foundation, speaking about the MIMC road show results. 
According to Federal Law No. 160 of 2015 "On the International Medical Cluster", this concerns the OECD member countries.